b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2543005/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543005/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Biotechnology" /><meta name="citation_title" content="Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)" /><meta name="citation_authors" content="Martina Inga Kirsch, Birgit H\xc3\xbclseweh, Christoph Nacke, Torsten R\xc3\xbclker, Thomas Schirrmann, Hans-J\xc3\xbcrgen Marschall, Michael Hust, Stefan D\xc3\xbcbel" /><meta name="citation_date" content="2008" /><meta name="citation_volume" content="8" /><meta name="citation_doi" content="10.1186/1472-6750-8-66" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2543005/?report=abstract" /><meta name="citation_pmid" content="18764933" /><meta name="DC.Title" content="Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Martina Inga Kirsch" /><meta name="DC.Contributor" content="Birgit H\xc3\xbclseweh" /><meta name="DC.Contributor" content="Christoph Nacke" /><meta name="DC.Contributor" content="Torsten R\xc3\xbclker" /><meta name="DC.Contributor" content="Thomas Schirrmann" /><meta name="DC.Contributor" content="Hans-J\xc3\xbcrgen Marschall" /><meta name="DC.Contributor" content="Michael Hust" /><meta name="DC.Contributor" content="Stefan D\xc3\xbcbel" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1186/1472-6750-8-66" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)" /><meta property="og:type" content="article" /><meta property="og:description" content="Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus group. Several species of this family are also pathogenic to humans and are recognized as potential agents of biological warfare and terrorism. The objective of this work was the generation ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543005/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2543005/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2543005/pdf/12896_2007_Article_335.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B33C3E99AC4410000000005470547.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2543005</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Biotechnology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Biotechnol</span>. 2008; 8: 66. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Sep 2. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1472-6750-8-66" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1472-6750-8-66</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2543005</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18764933">18764933</a></div></div></div></div><h1 class="content-title">Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kirsch%20MI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046219180096" co-class="co-affbox">Martina Inga Kirsch</a>,<sup>#</sup><sup>1</sup> <a href="/pubmed/?term=H%26%23x000fc%3Blseweh%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046227473728" co-class="co-affbox">Birgit H&#x000fc;lseweh</a>,<sup>#</sup><sup>2</sup> <a href="/pubmed/?term=Nacke%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046219175968" co-class="co-affbox">Christoph Nacke</a>,<sup>1</sup> <a href="/pubmed/?term=R%26%23x000fc%3Blker%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046219173600" co-class="co-affbox">Torsten R&#x000fc;lker</a>,<sup>1</sup> <a href="/pubmed/?term=Schirrmann%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046221035824" co-class="co-affbox">Thomas Schirrmann</a>,<sup>1</sup> <a href="/pubmed/?term=Marschall%20HJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046221033456" co-class="co-affbox">Hans-J&#x000fc;rgen Marschall</a>,<sup>2</sup> <a href="/pubmed/?term=Hust%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046221031088" co-class="co-affbox">Michael Hust</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>#</sup><sup>1</sup> and  <a href="/pubmed/?term=D%26%23x000fc%3Bbel%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933" class="affpopup" co-rid="_co_idm140046221028240" co-class="co-affbox">Stefan D&#x000fc;bel</a><sup>#</sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140046219180096"><h3 class="no_margin">Martina Inga Kirsch</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=Kirsch%20MI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Martina Inga Kirsch</a></div></div><div id="_co_idm140046227473728"><h3 class="no_margin">Birgit H&#x000fc;lseweh</h3><p><sup>2</sup>Armed Forces Scientific Institute for Protection Technologies &#x02013; NBC Protection (WIS), Humboldtstra&#x000df;e 1, 29633 Munster, Germany </p><div>Find articles by <a href="/pubmed/?term=H%26%23x000fc%3Blseweh%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Birgit H&#x000fc;lseweh</a></div></div><div id="_co_idm140046219175968"><h3 class="no_margin">Christoph Nacke</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=Nacke%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Christoph Nacke</a></div></div><div id="_co_idm140046219173600"><h3 class="no_margin">Torsten R&#x000fc;lker</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=R%26%23x000fc%3Blker%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Torsten R&#x000fc;lker</a></div></div><div id="_co_idm140046221035824"><h3 class="no_margin">Thomas Schirrmann</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=Schirrmann%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Thomas Schirrmann</a></div></div><div id="_co_idm140046221033456"><h3 class="no_margin">Hans-J&#x000fc;rgen Marschall</h3><p><sup>2</sup>Armed Forces Scientific Institute for Protection Technologies &#x02013; NBC Protection (WIS), Humboldtstra&#x000df;e 1, 29633 Munster, Germany </p><div>Find articles by <a href="/pubmed/?term=Marschall%20HJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Hans-J&#x000fc;rgen Marschall</a></div></div><div id="_co_idm140046221031088"><h3 class="no_margin">Michael Hust</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=Hust%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Michael Hust</a></div></div><div id="_co_idm140046221028240"><h3 class="no_margin">Stefan D&#x000fc;bel</h3><p><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </p><div>Find articles by <a href="/pubmed/?term=D%26%23x000fc%3Bbel%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18764933">Stefan D&#x000fc;bel</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140046222839776_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140046222839776_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140046222839776_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140046222839776_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Abteilung Biotechnologie, Institut f&#x000fc;r Biochemie und Biotechnologie, Technische Universit&#x000e4;t Braunschweig, Spielmannstra&#x003b2;e 7, 38106 Braunschweig, Germany </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Armed Forces Scientific Institute for Protection Technologies &#x02013; NBC Protection (WIS), Humboldtstra&#x000df;e 1, 29633 Munster, Germany </div><div><span class="fm-affl">Martina Inga Kirsch, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@hcsrik.anitram" class="oemail">ed.sb-ut@hcsrik.anitram</a></span>.</div><div><a href="#idm140046222839776aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140046222839776_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Dec 16; Accepted 2008 Sep 2.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140046222839776_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Kirsch et al; licensee BioMed Central Ltd. 2008</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2543005/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus group. Several species of this family are also pathogenic to humans and are recognized as potential agents of biological warfare and terrorism. The objective of this work was the generation of recombinant antibodies for the detection of VEEV after a potential bioterrorism assault or an natural outbreak of VEEV.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">In this work, human anti-VEEV single chain Fragments variable (scFv) were isolated for the first time from a human na&#x000ef;ve antibody gene library using optimized selection processes. In total eleven different scFvs were identified and their immunological specificity was assessed. The specific detection of the VEEV strains TC83, H12/93 and 230 by the selected antibody fragments was proved. Active as well as formalin inactivated virus particles were recognized by the selected antibody fragments which could be also used for Western blot analysis of VEEV proteins and immunohistochemistry of VEEV infected cells. The anti-VEEV scFv phage clones did not show any cross-reactivity with Alphavirus species of the Western equine encephalitis virus (WEEV) and Eastern equine encephalitis virus (EEEV) antigenic complex, nor did they react with Chikungunya virus (CHIKV), if they were used as detection reagent.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusion</h3><p id="__p3" class="p p-first-last">For the first time, this study describes the selection of antibodies against a human pathogenic virus from a human na&#x000ef;ve scFv antibody gene library using complete, active virus particles as antigen. The broad and sensitive applicability of scFv-presenting phage for the immunological detection and diagnosis of Alphavirus species was demonstrated. The selected antibody fragments will improve the fast identification of VEEV in case of a biological warfare or terroristic attack or a natural outbreak.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1472-6750-8-66) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Antibody Fragment, Venezuelan Equine Encephalitis Virus, Eastern Equine Encephalitis Virus, Infected Vero Cell, Antibody Phage Display</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">Venezuelan equine encephalitis virus (VEEV) belongs to the Alphavirus genus within the Togaviridae family and was first isolated from horses in the end of the 1930s [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050581">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050577">2</a>]. These viruses have a natural transmission cycle between rodents and mosquitos [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050658">3</a>]. Millions of horses were affected by this arbovirus with a fatality rate of up to 80% in epidemics in Central and South America [<a href="#CR4" rid="CR4" class=" bibr popnode">4</a>].</p><p id="__p6">Several species of this family are pathogenic to humans and are recognized as potential biological warfare agent (BWA) [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050603">5</a>]. VEEV is classified as Bioterrorism Agent Category B by the center of Disease Control (CDC). Alphaviruses do not only have the potential for illness and transmission, but they can also be produced in large quantities and are moderately easy to disseminate. Furthermore, these virus species have the capacity to cause human epidemics [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050675">6</a>&#x02013;<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050600">11</a>]. VEEV causes disease symptoms ranging from mild febrile reactions to fatal encephalitic zoonoses. Outcomes are significantly worse for young and elderly patients, with case fatalities ranging from 4 to 35% [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050654">12</a>, <a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050630">13</a>]. These viruses are highly infectious as aerosols [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050673">14</a>, <a href="#CR15" rid="CR15" class=" bibr popnode">15</a>] and an intentional release of sufficient quantities as inhalable small-particle aerosol is expected to infect a high percentage of individuals within an area of a least 10,000 km<sup>2</sup> [<a href="#CR16" rid="CR16" class=" bibr popnode">16</a>]. They can replicate in cell culture to very high titers and are relatively stable to environmental influences [<a href="#CR17" rid="CR17" class=" bibr popnode">17</a>].</p><p id="__p7">For the surveillance of possible bioterrorism targets and endangered populations, rapid detection and diagnosis of VEEV are of crucial importance. In the past, the generation of monoclonal murine antibodies has improved the fast identification of VEEV infections to locate human and equine outbreaks of encephalitis. On the other hand, monospecific diagnostic monoclonal antibodies (mAbs) against VEEV are either hardly available on the market or too expensive for extensive use. In view of these current limitations the generation of specific high affinity recombinant antibodies may significantly improve the current situation and can make the rapid immunological detection widely available.</p><p id="__p8">A promising method to generate recombinant antibodies against human pathogenic viruses like VEEV is the antibody phage display technology. Using antibody phage display, genotype and phenotype of an antibody fragment are linked by fusing the antibody gene fragment to the minor coat protein III gene of the filamentous bacteriophage M13. The resulting antibody fragment::pIII fusion protein is displayed on the surface of the phage particles [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050578">18</a>&#x02013;<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050576">21</a>]. The most common antibody formats used for this technology are the Fragment antigen binding (Fab) and the single chain Fragment variable (scFv). In comparison to the Fab, that is consisting of the Fragment determining (Fd) of the heavy chain and the light chain linked by a disulphide bond, the scFv simply consists of the variable region of the heavy chain (V<sub>H</sub>) and the variable region of the light chain (V<sub>L</sub>), connected by a short peptide linker [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050614">22</a>, <a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050666">23</a>]. The selection of antibody fragments from antibody gene libraries is performed by an <em>in vitro</em> selection process [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050572">24</a>, <a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050597">25</a>], that is also referred to as "panning".</p><p id="__p9" class="p p-last">In this study, we demonstrated the selection of human antibody fragments from a na&#x000ef;ve antibody gene library specific for the detection of VEEV. We describe their immunological properties and discuss their possible application of these antibodies for diagnosis and detection of VEEV after a potential bioterrorism assault or natural outbreak of VEEV.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Selection of recombinant antibodies against VEEV from a human na&#x000ef;ve antibody library</h3><p id="__p10" class="p p-first">In order to generate antibody fragments reactive to members of the VEE virus serocomplex the human naive scFv antibody gene library HAL4/7 was used. All pannings were performed in a biosafety level 3 laboratory and the vaccine strain, TC83, as a medically important and epizootic Alphavirus species was used as antigen.</p><p id="__p11">The phage library was subjected to 3 rounds of panning and representative phage clones were assessed for their ability to bind VEEV TC83 immobilized onto 96 microwell plates. In order to exclude the enrichment of false-positive phage, the binding to supernatant of non-infected Vero cells (VRS concentrated and unconcentrated) was determined. Furthermore, the non-specific bindings of scFv phage to the VEEV-specific capture antibodies mAb 8747 and mAb VEE-WIS without and with an non-specific antigen, like lysozyme, was examined. As shown in figure <a href="/pmc/articles/PMC2543005/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">figure1</span></span><span>1</span></a> a significant enrichment of VEEV-specific polyclonal antibody phage occurred after the third panning round. However, besides the specific accumulation of binders also a severe co-enrichment of antibodies to the capture antibodies was observed.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2543005/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046218192256" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig1_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig1_HTML.jpg" /></div><div id="largeobj_idm140046218192256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p12">ELISA with 10<sup>10</sup> (cfu) polyclonal scFv phage of each panning round. Antigen (directly immobilized): 1 &#x003bc;g VRS purified VEEV particles (VEEV VRS), 1 &#x003bc;g VRS concentrated supernatant from non-infected Vero cells (Vero VRS), 1:2 diluted supernatant of non infected VERO cells (Vero SN), 0.5 &#x003bc;g of each anti-VEEV capture mAb 8747 and VEE-WIS1, 1 &#x003bc;g lysozyme. The bound scFv phage were detected using mAb anti-M13 conjugated with HRP (1:5000).</p></div></div></div><p id="__p13" class="p p-last">Single clones were isolated from the third panning round. Soluble scFvs were produced in microtitre plates and analyzed by antigen ELISA on immobilized inactivated VEEV particles. The ELISA analysis using soluble scFvs instead of scFv phage minimized the occurance of false positives, because some antibody fragments bind only as antibody phage particles. Inactivated VEEV particles were used to ensure that the antibodies selected on active VEEV particles bound inactivated virus, too. In initial tests, we observed the enrichment of antibodies binding to Vero cell culture components. This effect was enhanced if VEEV particles were directly coated onto the wells and not captured by antibodies. Therefore, VRS purified Vero cell culture supernatant from non virus infected cells was used, because proteins from the cell culture supernatant were also enriched by the VRS system. In total, 230 antibody clones were analyzed by antigen ELISA (data not shown). Due to the signal to noise ratio, 26 VEEV binding scFv clones were further subjected to BstNI fingerprinting to sort out clones with identical restriction pattern (data not shown). After DNA sequencing, 10 different scFvs were finally found from this panning (designated with CHN24-x and MK269-x). One additional scFv clone (MK271-G2) was isolated by a slightly different panning strategy. Interestingly, only antibodies with lambda light chains were obtained. According to the integrative database of germ-line variable genes from the immunoglobulin loci of human (VBASE2) the isolated scFv fragments contained the antigen-binding variable domains of the light chains LV1, 2, 3 and 6. The heavy chains of the isolated scFvs belonged to the subfamily HV1, 3 and 4, while HV1 predominated (table <a href="/pmc/articles/PMC2543005/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(table1</span></span><span>1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p14">Anti-VEEV scFvs</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046224789728" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">scFv clone</th><th align="center" colspan="2" rowspan="1">VH</th><th colspan="1" rowspan="1"></th><th align="center" colspan="2" rowspan="1">VL</th></tr><tr><th rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">HV</th><th align="left" rowspan="1" colspan="1">D</th><th align="left" rowspan="1" colspan="1">HJ</th><th align="left" rowspan="1" colspan="1">LV</th><th align="left" rowspan="1" colspan="1">LJ</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CHN24-2-A1</td><td align="left" rowspan="1" colspan="1">IGHV1-69*01</td><td align="left" rowspan="1" colspan="1">IGHD2-8*02</td><td align="left" rowspan="1" colspan="1">IGHJ5*02</td><td align="left" rowspan="1" colspan="1">IGLV3-1*01</td><td align="left" rowspan="1" colspan="1">IGLJ3*01</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-A2</td><td align="left" rowspan="1" colspan="1">IGHV3-9*01</td><td align="left" rowspan="1" colspan="1">IGHD6-19*01</td><td align="left" rowspan="1" colspan="1">IGHJ3*02</td><td align="left" rowspan="1" colspan="1">IGLV3-1*01</td><td align="left" rowspan="1" colspan="1">IGLJ1*01</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-B7</td><td align="left" rowspan="1" colspan="1">IGHV1-18*01</td><td align="left" rowspan="1" colspan="1">IGHD2-21*02</td><td align="left" rowspan="1" colspan="1">IGHJ3*02</td><td align="left" rowspan="1" colspan="1">IGLV2-14*04</td><td align="left" rowspan="1" colspan="1">IGLJ3*01</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-C2</td><td align="left" rowspan="1" colspan="1">IGHV1-69*01</td><td align="left" rowspan="1" colspan="1">IGHD6-13*01</td><td align="left" rowspan="1" colspan="1">IGHJ3*02</td><td align="left" rowspan="1" colspan="1">IGLV3-21*01</td><td align="left" rowspan="1" colspan="1">IGLJ3*01</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-C3</td><td align="left" rowspan="1" colspan="1">IGHV3-23*01</td><td align="left" rowspan="1" colspan="1">IGHD6-13*01</td><td align="left" rowspan="1" colspan="1">IGHJ6*03</td><td align="left" rowspan="1" colspan="1">IGLV3-1*01</td><td align="left" rowspan="1" colspan="1">IGLJ1*01</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-D5</td><td align="left" rowspan="1" colspan="1">IGHV1-8*01</td><td align="left" rowspan="1" colspan="1">IGHD6-6*01inv</td><td align="left" rowspan="1" colspan="1">IGHJ6*02</td><td align="left" rowspan="1" colspan="1">IGLV2-14*04</td><td align="left" rowspan="1" colspan="1">IGLJ3*02</td></tr><tr><td align="left" rowspan="1" colspan="1">CHN24-2-F11</td><td align="left" rowspan="1" colspan="1">IGHV1-18*01</td><td align="left" rowspan="1" colspan="1">IGHD6-6*01</td><td align="left" rowspan="1" colspan="1">IGHJ4*02</td><td align="left" rowspan="1" colspan="1">IGLV6</td><td align="left" rowspan="1" colspan="1">IGLJ3*02</td></tr><tr><td align="left" rowspan="1" colspan="1">MK269-C10</td><td align="left" rowspan="1" colspan="1">IGHV3-30*04</td><td align="left" rowspan="1" colspan="1">IGHD5-5*01</td><td align="left" rowspan="1" colspan="1">IGHJ6*02</td><td align="left" rowspan="1" colspan="1">IGLV2-14*02</td><td align="left" rowspan="1" colspan="1">IGLJ1*01</td></tr><tr><td align="left" rowspan="1" colspan="1">MK269-E11</td><td align="left" rowspan="1" colspan="1">IGHV4-34*01</td><td align="left" rowspan="1" colspan="1">IGHD3-3*01</td><td align="left" rowspan="1" colspan="1">IGHJ4*02</td><td align="left" rowspan="1" colspan="1">IGLV1-51*02</td><td align="left" rowspan="1" colspan="1">IGLJ3*01</td></tr><tr><td align="left" rowspan="1" colspan="1">MK269-E12</td><td align="left" rowspan="1" colspan="1">IGHV4-4*02</td><td align="left" rowspan="1" colspan="1">IGHD2-21*01inv</td><td align="left" rowspan="1" colspan="1">IGHJ5*02</td><td align="left" rowspan="1" colspan="1">IGLV3-21*02</td><td align="left" rowspan="1" colspan="1">IGLJ3*01</td></tr><tr><td align="left" rowspan="1" colspan="1">MK271-G2</td><td align="left" rowspan="1" colspan="1">IGHV1-69*01</td><td align="left" rowspan="1" colspan="1">IGHD3-16*01</td><td align="left" rowspan="1" colspan="1">IGHJ6*02</td><td align="left" rowspan="1" colspan="1">IGLV3-21*02</td><td align="left" rowspan="1" colspan="1">IGLJ3*02</td></tr></tbody></table></div><div id="largeobj_idm140046224789728" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p15">Tab. 1. Given are the names of the gene segments according to VBASE2. Abbreviations: HV: V (variable) gene segments of the heavy chain; D: D (diversity) gene segment; HJ: J (joining) gene segment of the heavy chain; LV: V gene segment of the light chain; LJ: J gene segment of the light chain.</p></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Production and characterization of VEEV-specific scFv phage</h3><p id="__p16" class="p p-first-last">In order to prove the presentation of functional scFvs on the selected monoclonal scFv phage clones, the clones were subjected to immunoblot analysis. ScFv phage were separated by SDS-PAGE under reducing conditions and the corresponding immunoblot was stained using an anti-pIII mAb. All scFv phage preparations showed a nearly equal and efficient display of scFv antibodies on their surface. This straightly allows to compare the cognate ELISA, Western blot and immunohistochemistry results. The anti-pIII immunoblot of a selection of anti-VEEV scFv phage is shown in figure <a href="/pmc/articles/PMC2543005/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">figure2</span></span><span>2</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2543005/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046223700160" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig2_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig2_HTML.jpg" /></div><div id="largeobj_idm140046223700160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p17">Immunoblot of anti-VEEV scFv phage. 1 &#x000d7; 10<sup>11</sup> (cfu) scFv phage per lane were separated on a reducing 10% SDS-PAGE, followed by Western blot and detection of wildtype pIII or scFv::pII fusion using mouse mAb anti-pIII (1:2000) and goat anti-mouse HRP (1:5000). A selection of seven anti-VEEV scFv phage clones is shown.</p></div></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">Verification of the VEEV-specific immunoreaction with scFv phage and scFv-Fc fusions</h3><p id="__p18" class="p p-first">In order to evaluate whether the antibody format or design influences the specific binding capacity, ELISA results obtained with selected scFv phage (figure <a href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure3A)</span></span><span>3A</span></a>) and their corresponding scFv-Fc fusions (figure <a href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure3B)</span></span><span>3B</span></a>) were compared. Purified formalin inactivated VEEV TC83 antigen was immobilized onto microwells and serial dilutions of either anti-VEEV scFv phage or serial dilution of scFv-Fc fusion proteins were used for detection. All selected scFv phage clones and the corresponding scFv-Fc fusions were able to bind directly immobilized VEEV particles (figure <a href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure3).</span></span><span>3</span></a>). The background binding of the control antibody IIB6 scFv phage increased when using very high scFv phage particle concentrations. A scFv phage concentration of about 1 &#x000d7; 10<sup>9</sup> &#x02013; 5 &#x000d7; 10<sup>9</sup> scFv phage particles, respectively 10&#x02013;100 ng/mL scFv-Fc fusion proteins are well suited for the detection of immobilized VEEV particles. Additionally, it was also possible to detect direct immobilised active VEEV TC83 particles by ELISA using scFv phage (figure <a href="/pmc/articles/PMC2543005/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure4A),</span></span><span>4A</span></a>), respectively scFv-Fc fusion proteins (figure <a href="/pmc/articles/PMC2543005/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure4B</span></span><span>4B</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046217375280" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig3_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig3_HTML.jpg" /></div><div id="largeobj_idm140046217375280" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p19">ELISA on directly immobilized inactive VEEV particles. Antigen: 1 &#x003bc;g VRS purified VEEV particles. <strong>A</strong>. A dilutions series of scFv phage particles were used for VEEV detection. The scFv phage were detected using mAb anti-M13 conjugated with HRP (1:5000). The mean values of two ELISAs from two independent scFv phage productions are shown. <strong>B</strong>. A series of scFv-Fc fusion protein dilutions were used for VEEV detection. The scFv-Fc were detected using goat anti-human IgG Fc specific antibody conjugated with HRP (1:20000). IIB6 is a non VEEV-specific control scFv antibody.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC2543005/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046220729008" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig4_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig4_HTML.jpg" /></div><div id="largeobj_idm140046220729008" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p20">ELISA on directly immobilized active VEEV particles. Antigen: 1 &#x003bc;g VRS purified VEEV particles or 1 &#x003bc;g VRS concentrated supernatant from non-infected Vero cells as control. <strong>A</strong>. 1 &#x000d7; 10<sup>9</sup> scFv phage per well were used for VEEV detection. The scFv phage were detected as described in figure 3. The mean values of two ELISAs from two independent scFv phage productions are shown. <strong>B</strong>. 10 ng per well (100 ng/mL) scFv-Fc were used for VEEV detection. The scFv-Fc were detected as described in figure 3.</p></div></div></div><p id="__p21" class="p p-last">SDS-PAGE and Western blotting are valuable approaches to examine which VEEV structural proteins are recognized by the selected anti-VEEV antibody fragments. Since the viral glycoproteins E1 and E2 can be separated from each other under non-reducing conditions, virus samples were first disintegrated by incubation for 20 minutes at 56&#x000b0;C in Laemmli sample buffer containing no 2-mercaptoethanol. The samples were separated by 10% SDS-PAGE, blotted onto a PVDF membrane and stained as described. In general 5 &#x000d7; 10<sup>10</sup> anti-VEEV scFv phage/mL were used for the specific detection of structural proteins (Fig. <a href="/pmc/articles/PMC2543005/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3A).</span></span><span>3A</span></a>). The E2 protein specific antibodies mAb 8747 (Chemicon, CA, USA) and mAb 8/6 (Greiser-Wilke et al., 1989) served as positive control and displayed the expected electrophoretic profile typical for the Alphavirus E2 protein (46,9 kDa) and the cognate viral E1/E2 heterodimer (94,8 kDa). Interestingly, under non reducing conditions most of the anti-VEEV scFv phage displayed a nearly similar binding pattern and were able to bind either the E1 or E2 glycoprotein and the corresponding heterodimer (figure <a href="/pmc/articles/PMC2543005/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure5A).</span></span><span>5A</span></a>). However, several of the specific scFv phage also caused an undefined smear if used in immunoblot analysis. This might be explained by prolonged staining. If the corresponding scFv-Fc fusions were used for binding, clear and defined bands, representing either E1 or E2 protein, were detectable similar to the E2 glycoprotein positive controls in figure <a href="/pmc/articles/PMC2543005/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">figure5B.</span></span><span>5B</span></a>. In contrast, if virus samples were either prepared under reducing conditions or boiled prior to SDS-PAGE, no specific binding was observed. Therefore, the epitopes recognized by the scFv phage and scFv-Fc fusions are likely to be conformation dependent and the secondary structure seems to be critical for the binding of viral structural proteins. None of the isolated scFv fragments identified any linear epitopes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC2543005/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046225335168" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig5_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig5_HTML.jpg" /></div><div id="largeobj_idm140046225335168" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p22">Immunoblot analysis of VEEV antigen detected by scFv phage or scFv-Fc fusions. VEEV VRS preparations were prepared at 56&#x000b0;C under non-reducing conditions and separated by 10% SDS-PAGE. After Western blot membranes were cut in stripes corresponding to 5&#x02013;6 &#x003bc;g VEEV proteins. <strong>A</strong>. Immunostain was performed with 5 &#x000d7; 10<sup>10</sup> (cfu) anti-VEEV scFv phage particles/mL, murine anti-VEEV mAbs 8/6 and 8747 (1:1000) and detected with mAb mouse anti-M13 HRP (1:4000), respectively goat anti-mouse IgG Fc specific HRP (1:10000). IIB6 is a non VEEV-specific control scFv phage. <strong>B</strong>. Additionally, VEEV VRS samples were prepared at 56&#x000b0;C under non-reducing or at 99&#x000b0;C under reducing conditions, respectively. Western blots were stained with 1 &#x003bc;g/mL scFv-Fc and murine anti-VEEV IgG (1:1000) and detected with goat anti-human (gamma chain specific) AP (1:5000), or goat-anti mouse (Fc specific) AP (1:10000), respectively. The marker bands were marked with a pencil.</p></div></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Evaluation of the cross-reactivity with different Alphavirus species and subspecies</h3><p id="__p23" class="p p-first">In order to test the cross-reactivity of the selected antibody clones with other strains of the VEEV as well as with other antigenic complexes, their binding was evaluated in a sandwich antigen catch ELISA by using an Alphavirus specific mAb mixture for capturing and the selected scFv phage for detection.</p><p id="__p24">An established VEEV-specific (figure <a href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure6A)</span></span><span>6A</span></a>) and Alphavirus genus-specific sandwich ELISA (figure <a href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure6B)</span></span><span>6B</span></a>) served as positive control. As negative control, cell culture of non-infected Vero cells was used. As marker antibody the biotinylated anti-VEEV mAb 8/6 was used for the detection of all VEEV strains (figure <a href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure6A)</span></span><span>6A</span></a>) and a biotinylated mixture of antibodies consisting of mAb 8/6, mAb VEE-WIS1, mAb 12/2 and mAb 42/2 was used for the group specific detection of Alphaviruses (figure <a href="/pmc/articles/PMC2543005/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure4B).</span></span><span>4B</span></a>). All viral antigens were captured by either the VEEV-specific mAb VEEV-WIS1 or a mAb mixture of anti-Alphavirus antibodies, consisting of mAb 3/4, mAb 12/2 and mAb VEE-WIS1 (WIS, Munster, Germany). Some virus strains (VEE-230) were captured better than others (VEE-H12/93).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046226554480" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig6_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig6_HTML.jpg" /></div><div id="largeobj_idm140046226554480" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p25">Cross-reactivity of the anti-VEEV scFv clones and different anti-Alphavirus specific mAbs analyzed by ELISA. Antigens: VEEV strains TC83, 230 and H12/93 were captured by using anti-VEEV mAb VEE-WIS1 (3 &#x003bc;g/mL); Eastern equine encephalitis virus (EEE), Western equine encephalitis virus (WEE) and Chikungunya (CHIK) were captured by using an anti-Alphavirus mAb mix consisting of mAb 3/4, mAb 12/2 and mAb VEE-WIS1 (3 &#x003bc;g/mL); Culture supernatant of non-infected Vero cells was captured once by anti-VEEV mAb VEE-WIS1 (VERO VEEWIS1) or by a mAb mix consisting of mAb 3/4, mAb 12/2 and mAb VEE-WIS1 (VERO mAb mix). <strong>A</strong>. Staining with biotinylated anti-VEEV mAb 8/6 (1:10000) and streptavidin conjugated with HRP (1:4000). <strong>B</strong>. Staining with a biotinylated mixture of antibodies consisting of mAb 8/6 (1:10000), mAb VEE-WIS1 (1:10000), mAb 12/2 (1:5000) and mAb 42/2 (1:2000) followed by a streptavidin-HRP (1:4000) incubation. <strong>C</strong>. Staining with 1 &#x000d7; 10<sup>9</sup> (cfu) scFv phage per well was followed by an incubation with mAb anti-M13 conjugated with HRP (1:5000). The IIB6 scFv phage was used as negative control. The mean values of two ELISAs from two independent scFv phage productions are shown.</p></div></div></div><p id="__p26">All VEEV antigens were employed with a nearly similar TCID<sub>50</sub>/mL of 3 &#x000d7; 10<sup>8</sup> to 1 &#x000d7; 10<sup>9</sup>. In addition to the VEEV vaccine strain TC83 of subtype IAB, the USSR (Russian) vaccine strain VEEV 230 and the British NCPV strain VEEV 12/93 were applied. Furthermore, the selected scFv clones were tested for the specific detection of Eastern equine encephalitis virus (EEEV) strain H178/99, Western equine encephalitis virus (WEEV) strain H160/99 and Chikungunya virus (CHIKV) strain S27 Petersfield.</p><p id="__p27">Positive ELISA signals were obtained for the different VEEV strains with all tested scFv phage clones (figure <a href="/pmc/articles/PMC2543005/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(figure6C).</span></span><span>6C</span></a>). In contrast, the scFv CHN-24-2A1 showed a comparable low antigen binding. Maximum binding in the antigen sandwich ELISA was found for the Russian strain VEEV 230. This might be explained by the fact that this virus sample was chemically inactivated prior to use. We suppose that dependent on the inactivation the critical epitopes are more accessible for antibody detection.</p><p id="__p28" class="p p-last">However, none of the selected anti-VEEV scFv phage showed any cross-reactivity with other Alphaviruses, when used as detection antibody. All positive controls exhibited the expected binding pattern and were captured and detected by their specific mAbs in the ELISA.</p></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">Detection of VEEV antigen in lysates of infected Vero cells</h3><p id="__p29" class="p p-first">In order to examine the broad immunological applicability of the selected scFvs, we also tested the recombinant antibody fragments for the specific detection of VEEV TC83 in lysates of infected Vero cells. These cell lysates were prepared by disrupting infected cells with 4 M urea while coupled to microwells. Detection was performed with scFv phage followed by an incubation with mAb anti-M13 conjugated to HRP. Lysates of non-infected Vero cells and VEEV antigen incubated with the mAb II-B6 served as negative control.</p><p id="__p30">Specific binding could be confirmed for nearly all selected antibody fragments except for the clones CHN24-2-A1 and MK269-E11. The most stringent binding results were obtained with the scFv clones CHN24-2-A2, CHN24-2-C3, CHN24-2-F11 and MK271-G2 (Fig. <a href="/pmc/articles/PMC2543005/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.7</span></span><span>7</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC2543005/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140046219623952" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12896_2007_Article_335_Fig7_HTML.jpg" src="/pmc/articles/PMC2543005/bin/12896_2007_Article_335_Fig7_HTML.jpg" /></div><div id="largeobj_idm140046219623952" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2543005/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC2543005/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p31">ELISA on VEEV infected cell lysate. Antigen: cell lysate from VEEV infected/non-infected Vero cells. VEEV was detected by using 1 &#x000d7; 10<sup>9</sup> (cfu) scFv phage per well followed by an incubation with mAb anti-M13 conjugated with HRP (1:5000). The IIB6 scFv phage was used as negative control. The mean values of two ELISAs from two independent scFv phage productions are shown.</p></div></div></div><p id="__p32" class="p p-last">In addition, detection of VEEV-specific antigen by immunohistochemistry in TC83 infected and formaldehyde fixed Vero cells was possible. Similar to the results described above, all scFv clones, except for clone CHN24-2-A1, showed a specific cytoplasmic immunostaining of VEEV infected Vero cells (data not shown).</p></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Discussion</h2><p id="__p33" class="p p-first">For the detection of VEEV after an potential bioterrorims assault, e.g. by use of a VEEV aerosol, or a natural outbreak of VEEV, a fast diagnosis of these pathogen is necessary. The present work describes for the first time the screening and isolation of anti-VEEV antibody fragments from a human na&#x000ef;ve antibody gene library by phage display. Ten out of eleven scFv clones were selected by the panning strategy using a mAb mixture for virus capturing as described. One further clone, MK271-G2, was isolated by an alternative panning, that was performed on directly immobilized viral antigen. The use of antibody captured virus particles was the preferred panning strategy because preliminary tests revealed, that panning on directly immobilized VEEV antigen enhanced especially the enrichment of non-specific binders.</p><p id="__p34">To our knowledge, there are no studies demonstrating the successful <em>in vitro</em> antibody selection against human pathogen complete virus particles using na&#x000ef;ve antibody gene libraries. A successful panning against severe acute respiratory syndrome coronavirus using a human semisynthetic library is described by van den Brink et al. [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050571">26</a>]. In most other studies recombinant or purified virus proteins were used for panning if using a na&#x000ef;ve antibody gene library [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050620">27</a>&#x02013;<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050682">29</a>]. The pannings using complete particles are mostly performed using immune libraries, e.g de Carvalho et al. [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050650">30</a>], Koch et al. [<a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050617">31</a>] or Duan et al. [<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050580">32</a>]. The panning procedure described here might be also useful for the <em>in vitro</em> antibody selection of scFvs against other viral targets from human na&#x000ef;ve antibody gene libraries, in particular when either immunized patients are not available or immunisation is not ethically feasible.</p><p id="__p35">Nearly all scFvs were able to detect active as well as inactive VEEV TC83 viral antigen. Comparable indirect ELISA data were obtained with scFv phage and their corresponding scFv-Fc fusions. The specific immunoreaction could be verified by Western blot analysis, immunohistochemistry and by immunostaining of urea disrupted cell lysates. The selected antibody clones were reactive with all tested members of the VEE virus serocomplex but showed no significant cross-reactivity with closely related Alphavirus species like WEEV, EEEV and CHIKV, if used as detection molecules.</p><p id="__p36">All Alphaviruses share a number of structural, sequential and functional similarities. Immunological typing approaches categorize the nearly 30 species into seven serocomplexes or species. The nucleotide and amino acid identity among these antigenic complexes, subtypes and varieties varies from 45 to 96 % [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050589">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050575">3</a>, <a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050644">33</a>, <a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050574">34</a>]. In general, the sequences of structural proteins are more divergent than the sequences of non-structural proteins. In immunoblot analysis the anti-VEEV scFv phage displayed a similar binding pattern like the E2 protein specific antibodies mAb 8747 (Chemicon, CA, USA) and mAb 8/6 [<a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050610">35</a>] and identified probably the E2 glycoprotein and the cognate viral E1/E2 heterodimer. Interestingly, all obtained scFv clones identified structural epitopes that are still folded after denaturation at 56&#x000b0;C under non-reducing conditions. In contrast, if the viral antigens were either prepared under reducing conditions or boiled prior to SDS-PAGE, no specific binding was observed.</p><p id="__p37">A possible neutralisation activity of the selected scFvs has to be assessed in further studies. Normally, the protective immunity to Alphaviruses is associated with an antibody reactivity to the virion glycoproteins E2 and so far, six conformationally stable epitopes were identified as critical for virus neutralization [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050662">36</a>&#x02013;<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050583">40</a>]. Furthermore our antibodies are fully human and therefore better suited for applications like as passive vaccination than murine antibodies.</p><p id="__p38" class="p p-last">To date, VEEV diagnosis is performed using monoclonal and polyclonal antibodies [<a href="#CR41" rid="CR41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050573">41</a>] and also scFv fragments have been analysed [<a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050624">42</a>]. This study showed that scFv phage are applicable for a broad range of anti-VEEV diagnosis assays: antigen ELISA on purified virus particles, ELISA on cell lysate and immunoblot. Furthermore, the recombinant fragments offer the possibility to develop a VEEV-specific diagnosis assay since the specific scFv phage can be easily produced and purified in high amounts. This could be an alternative to fullsize IgGs for an ELISA assay. At least, they might be applied for immuno-PCR [<a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050633">43</a>] in order to increase the sensitivity of detection. These methods can be used for the diagnosis of VEEV in the enviroment and for the detection of human or equine VEEV infections.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Conclusion</h2><p id="__p39" class="p p-first-last">For the first time, this study describes the selection of antibodies against a human pathogenic virus from a human na&#x000ef;ve scFv antibody gene library using complete, active virus particles as antigen. The described antibody selection procedure may also be useful for the <em>in vitro</em> antibody selection of antibody fragments against other viral targets from human na&#x000ef;ve antibody gene libraries, in particular when immunized patients are not available or immunisation is not ethically feasible. The broad and sensitive applicability of anti-VEEV scFv-presenting phage for the immunological detection and diagnosis of Alphavirus species was demonstrated. The selected recombinant antibody fragments will improve the rapid and specific detection of VEEV infections after human and equine outbreaks of encephalitis, where an early and definite identification is of critical importance.</p></div><div id="Sec10" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec10title">Methods</h2><div id="Sec11" class="sec sec-first"><h3 id="Sec11title">Cell culture and virus production</h3><p id="__p40" class="p p-first-last">Alphaviruses were grown in Vero cells (VERO-B4, African green monkey kidney cells, DSMZ-ACC 33, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany) in biosafety level 2 and 3 facilities according to standard procedures [<a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050593">35</a>]. Virus titers were determined by the 50 % tissue culture infective dose (TCID<sub>50</sub>/mL) method [<a href="#CR44" rid="CR44" class=" bibr popnode">44</a>, <a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]. All viruses used in this study represent models for biowarfare agent relevant Alphavirus species and are either part of the strain collection of the Armed Forces Scientific Institute for Protection Technologies &#x02013; NBC Protection (WIS) or were received from the National Collection of Pathogenic Viruses (NCPV), UK. The viruses used in this study were VEEV strain TC83 (variety 1AB), VEEV strain 12/93, Eastern equine encephalitis virus (EEEV) strain H178/99, Western equine encephalitis virus (WEEV) strain H160/99 and Chikungunya virus (CHIKV) strain S27. The strain TC83 was obtained from the Trinidad donkey strain by serial passages on guinea pig embryo heart cells in 1960 [<a href="#CR46" rid="CR46" class=" bibr popnode">46</a>]. Additionally, VEEV strain 230 antigen (inactivated by &#x003b2;-propiolactone) was purchased from Senova GmbH (Jena, Germany). Strain VEEV 230 is the former USSR vaccine strain. Its history of production is not exactly known but it has been produced by serial passages of a virulent natural strain on chick embryos [<a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050607">47</a>]. If not particularily indicated, active virus material was used throughout the study. Lysates of VEEV infected cells were prepared by incubation with 4 M urea for 15 min at room temperature (RT).</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Purification of Alphaviruses</h3><p id="__p41" class="p p-first">Virus containing supernatants from infected Vero cells were either purified by affinity chromatography on Matrex Cellufine Sulfate Medium&#x02122; (<em>Virus Recovery System</em>, VRS, Chisso America Inc., NY, USA) or by isopycnic density gradient centrifugation. Matrex Cellufine Sulfate Medium&#x02122; (VRS) is a cellulose bead medium functionalized with a low concentration of sulfate esters that operates similar to a cation-exchange resin and has a high affinity to enveloped viruses. It selectively adsorbs complete virus particles as well as viral coats according to their charge. Briefly, 50 mL resin was equilibrated with adsorption buffer (0.01 M phosphate buffer, pH 7.5). Up to 200 mL of virus containing prefiltered cell culture supernatant was loaded onto the column which then was washed twice with 0.01 M phosphate buffer, pH 7.5. Elution of virus particles was performed with 1 M NaCl.</p><p id="__p42" class="p p-last">Virus particles were pre-purified using ultracentrifugation through the sucrose cushion method (20% sucrose cushion), which causes low mechanical stress and allows the concentration and collection of morphologically intact particles after centrifugation at 112,000 &#x000d7; g for 2 to 3 hours. The pellet was resuspended in 0.5 to 1 mL phosphate buffered saline (PBS; [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>]) and further purified by isopycnic density gradient centrifugation (20 to 60 % sucrose) for 18 hours at 217,500 &#x000d7; g. The virus containing fraction was removed, stored at -80&#x000b0;C until subjected to further analysis.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Selection of recombinant antibodies</h3><p id="__p43" class="p p-first">The panning procedure based on protocols by Hust et al. [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050680">25</a>] with numerous modifications in 96 well microtitre plates (Maxisorb, Nunc, Wiesbaden, Germany). The mAb 8747 (Chemicon, Temecula, USA; [<a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050647">42</a>]) and mAb VEE-WIS1 (WIS, Munster, Germany) were incubated in concentrations of 1,5 &#x003bc;g/mL each overnight at 4&#x000b0;C in microtitre wells, followed by blocking with 1% (w/v) BSA in PBST (phosphate buffered saline + 1% Tween 20; [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>]) for 1 h at RT. For every panning round one well was coated for the selection and one well was coated for a preselection step. For the preselection step 50 &#x003bc;L VRS concentrated supernatant from non-infected Vero cells + 50 &#x003bc;L 1% BSA in PBST was incubated. Afterwards, the wells were blocked with 2% skim milk powder in PBST. After 2 h at RT the wells were washed three times with PBST. In parallel, for selection, 50 &#x003bc;L VRS purified VEEV (2.7 mg/mL) + 50 &#x003bc;L 1% BSA in PBST was captured for 1 h by gently shaking at RT, followed by overnight incubation at 4&#x000b0;C.</p><p id="__p44" class="p p-last">The human na&#x000ef;ve HAL4/7 antibody gene library [<a href="#CR49" rid="CR49" class=" bibr popnode">49</a>] consisting of in 5 &#x000d7; 10<sup>9</sup> independent clones in total based on the phagemid vector pHAL14 [<a href="#CR49" rid="CR49" class=" bibr popnode">49</a>, <a href="#CR50" rid="CR50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844967570">50</a>] was used for panning. The library was packaged using Hyperphage [<a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050586">51</a>&#x02013;<a href="#CR53" rid="CR53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050677">53</a>]. Prior to panning 5 &#x000d7; 10<sup>11</sup> scFv phage particles of HAL4 (kappa V<sub>L</sub> repertoire) and 5 &#x000d7; 10<sup>11</sup> scFv phage particles of HAL7 (lambda V<sub>L</sub> repertoire) were mixed with 150 &#x003bc;L &#x0201e;panningblock" solution (1% (w/v) BSA +1% (w/v) skim milk in PBST). In the preselection step, the library phage suspension was incubated at RT for 2.5 h in the well with captured VRS concentrated supernatant from non-infected Vero cells to remove non-specific binders. The supernatant containing the depleted library was mixed with 1/10 volume of VRS concentrated supernatant from non-infected Vero cells and 5 &#x003bc;g of a non VEEV-specific murine IgG for competition. For the selection step, the library solution was incubated in the wells with the immobilised VEEV at RT for 2 h followed by 30 times washing with PBST. Afterwards the bound scFv phage particles were eluted with 200 &#x003bc;L trypsin solution (10 &#x003bc;g/mL trypsin in PBS) at 37&#x000b0;C for 30 min. The supernatant containing the eluted scFv phage was transferred into a new tube. For the inactivation of the VEEV particles, 100 &#x003bc;L of 0.1 M glycin buffer pH 2.2 were added and incubated at RT for 15 min. The solution was neutralized with 100 &#x003bc;L 0.1 M phosphate buffer pH 7.6. 10 &#x003bc;L of eluted scFv phage were used for titration as described by Hust et al. [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050640">25</a>]. The remaining scFv phage were amplified as described by Hust et al. [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050627">25</a>] and used for the next panning round. The second panning round using the amplified phage was performed with the following modifications: the amount of antigen was reduced by 50% and washing cycles during panning were increased to 60. Additionally, in the third panning round the amount of antibody phage was reduced to 1 &#x000d7; 10<sup>9</sup> scFv phage. Furthermore, cell culture supernatant from non-infected Vero cells, 1/10 volume, was used for competition.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Antigen ELISA using scFv phage, scFvs and scFv-Fc fusions</h3><p id="__p45" class="p p-first-last">All ELISAs were performed in 96 microtitre well plates (Maxisorb&#x02122;, Nunc) that were coated with VRS purified viral antigen overnight at 4&#x000b0;C. Afterwards the wells were washed three times with PBST and blocked with 2% (w/v) skim milk powder in PBST (M-PBST) or with 1% fetal calf serum (FCS) in PBST for 1.5 h at RT, followed by three washes with PBST. ScFv phage, soluble antibody fragments or scFv-Fc fusion proteins were diluted in 100 &#x003bc;L M-PBST and incubated with the antigen for 1.5 h, followed by five washes with PBST. Bound scFv phage were detected by using the mAb anti-M13 conjugated with horseradish peroxidase (HRP) (GE Healthcare, M&#x000fc;nchen, Germany; 1:5.000). Bound soluble antibody fragments were detected by using the murine mAb 9E10 which recognizes the c-terminal c-myc tag. Staining was performed with a goat anti-mouse Ab conjugated to HRP (Sigma; 1:10.000). The specific binding of scFv-Fc fusion proteins to viral antigen was assessed with a goat anti-human Fc specific mAb conjugated to HRP (Sigma; 1:20.000), biotinylated mAbs were detected by using a Streptavidin HRP conjugate (GE Healthcare; 1:4.000). The visualization was performed with TMB (3,3\',5,5\'-tetramethylbenzidine) as substrate and the staining reaction was stopped by adding 100 &#x003bc;l 1 M sulphuric acid. Absorbance at 450 nm was measured by using a SUNRISE&#x02122; microtiter plate reader (Tecan, Crailsheim, Germany).</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Production of soluble antibody fragments in microtitre plate wells</h3><p id="__p46" class="p p-first-last">Microtitre plate wells containing 200 &#x003bc;L 2xTY + 100 mM glucose + 100 &#x003bc;g/mL ampicillin (2xTY-GA) were inoculated with single <em>E. coli</em> colonies from the phage titration of the panning and incubated overnight at 37&#x000b0;C and with constant shaking at 1200 rpm. 200 &#x003bc;L 2xTY-GA was inoculated with 10 &#x003bc;L of the overnight culture and grown at 37&#x000b0;C and 1200 rpm for 2 h. Bacteria were harvested by centrifugation for 10 min at 3220 &#x000d7; g. The pellets were resuspended in 200 &#x003bc;l 2xTY + 100 &#x003bc;g/mL Ampicillin + 50 &#x003bc;M isopropyl-beta-D-thiogalacto-pyranoside (IPTG), a substance that induces the prokaryotic <em>lacZ</em> promotor in <em>E. coli</em>, and incubated at 30&#x000b0;C and 1200 rpm overnight. Cells were removed from the scFv containing supernatant by centrifugation for 10 min at 3220 &#x000d7; g and 4&#x000b0;C.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Sequencing</h3><p id="__p47" class="p p-first-last">Sequencing was performed using ABI Prism 310 Genetic Analyzer according to the manufacturers instructions using oligonucleotide primer MKpelB_f (5\' GCCTACGGCAGCCGCTGG 3\') or MKmyc_r (5\' GATCCTCTTCTGAGATGAG 3\'). The antibody gene fragments were analyzed by using VBASE2 <a href="http://www.vbase2.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.vbase2.org</a>[<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050670">54</a>, <a href="#CR55" rid="CR55" class=" bibr popnode">55</a>].</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">SDS-PAGE and immunoblot analysis</h3><p id="__p48" class="p p-first">In order to analyse the scFv presentation on phage, the SDS-PAGE (sodium dodecyl sulphate-polyacrylamid gel electrophoresis) of scFv phage followed by Western blot and immunostaining of pIII were performed as described by Kirsch et al. [<a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050579">56</a>].</p><p id="__p49" class="p p-last">ScFv-Fc fusion proteins and scFv phage were used to detect VEEV proteins. VEEV particles were separated by SDS-PAGE and blotted onto PVDF membrane. The membrane was blocked with M-PBST for 1 h at RT. ScFv phage or the scFv-Fc fusion protein were incubated for 1.5 h at RT, followed by two times washing with PBST. For the detection of bound scFv phage mAb mouse anti-M13 conjugated with HRP (GE Healthcare, 1:4000) was used for detection and visualized by DAB (diaminobenzidine). For the detection of the scFv-Fc fusion protein goat anti-human (Fc specific) conjugated with alcaline phosphatase (AP) (Dianova, Hamburg, Germany, 1:5000) was used. Murine IgGs were detected using goat anti-mouse (Fc specific) conjugated with AP (Sigma, 1:10000) and visualised by NBT/BCIP.</p></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">Cloning and production of scFv-Fc fusion proteins</h3><p id="__p50" class="p p-first-last">VEEV-specific scFv gene fragments were subcloned from the library vector pHAL14 into the mammalian expression vector pCMV-hIgG1-Fc-XP (Schirrmann, manuscript in preparation) between the murine IgG signal peptide and the human IgG1 gene fragments by using the restriction sites <em>Nco</em>I and <em>Not</em>I. For the transient production of VEEV-specific scFv-Fc fusion proteins, the human embryonic kidney (HEK) cell line, 293T (American Type Culture Collection, ATCC, Rockwell, MD, No. CRL-11268) was transiently transfected by using the cell line specific lipid transfection reagent HEKfectin (Bio-Rad, M&#x000fc;nchen, Germany). 5 &#x000d7; 10<sup>5</sup> HEK293T cells were seeded and cultivated overnight into six well tissue culture plates (Sarstedt, N&#x000fc;rnbrecht, Germany) with 2 mL Dulbecco\'s Modified Eagle Medium (DMEM), supplemented with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate and 4.5 g/L glucose, 8% (v/v) fetal calf serum (FCS) and 1% (w/v) penicillin/streptomycin (PAA, Parsing, Austria) at 37&#x000b0;C in 7% CO<sub>2</sub> atmosphere and at 95% humidity. For the transfection 2.5 &#x003bc;g of plasmid DNA, encoding the scFv-Fc gene construct and 10 &#x003bc;L HEKfectin were preincubated in DMEM before the DNA-liposome complexes were then added to the HEK cells. The cells were incubated overnight with the transfection mixture before the medium was exchanged to fresh one on the following day. After 72 hours culture supernatants containing the scFv-Fc fusion proteins were harvested. The scFv-Fc fusion protein content of the collected supernatants was analyzed using a human IgG capture ELISA as previously described [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844050637">57</a>].</p></div></div><div id="idm140046221697728" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140046221697728title">Acknowledgements</h2><div class="sec"><p id="__p62">We would like to thank Lars Toleikis for providing the mucin specific control antibody IIB6. We gratefully acknowledge the kind help of Svetlana Mollova, Ida Retter and Werner M&#x000fc;ller for adapting VBASE2 to analysis of antibody V-gene sequences directly derived from antibody selection projects. We would like to thank Luzie Voss and Saskia Helmsing for technical assistance. We would like to thank Steven R. Talbot for corrections and carefully reading the manuscript. We gratefully acknowledge the financial support by the German ministry of defense (BMVg) and the financial support by the German ministry of education and research (BMBF, SMP "Antibody Factory" in the NGFN2 program).</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec19" class="sec sec-first"><h3 id="Sec19title">Authors&#x02019; original submitted files for images</h3><p id="__p51" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(29K, pdf)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(492K, pdf)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(243K, pdf)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(54K, pdf)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(324K, pdf)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(68K, pdf)</sup></span><span class="sup-box" id="MOESM7"><a href="/pmc/articles/PMC2543005/bin/12896_2007_335_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 7</a><sup>(25K, pdf)</sup></span></p></div></div><div id="idm140046220768800" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140046220768800title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140046220768672"><p id="__p59" class="p p-first-last">Martina Inga Kirsch, Birgit H&#x000fc;lseweh, Michael Hust and Stefan D&#x000fc;bel contributed equally to this work.</p></p><p class="fn sec" id="idm140046220767920"><p id="__p60" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p61" class="p p-last">MIK, BH performed the most experiments and helped to draft the manuscript. CN and TR performed some of the experiments. In addition, BH participated in the design and coordination of the study. TS and HJM particpated in the design and coordination of the study and helped to draft the manuscript. MH drafted the manuscript, participated in the design and coordination of the study and performed some of the experiments. SD conceived the project and wrote the grant application, particpated in the design and coordination of the study and helped to draft the manuscript. All authors read and approved the final manuscript.</p></p></div></div><div id="idm140046222839776aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140046222839776aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Martina Inga Kirsch, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@hcsrik.anitram" class="oemail">ed.sb-ut@hcsrik.anitram</a></span>.</p><p><span class="fm-affl">Birgit H&#x000fc;lseweh, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.bwb@hewesleuhtigrib" class="oemail">gro.bwb@hewesleuhtigrib</a></span>.</p><p><span class="fm-affl">Christoph Nacke, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.xmg@ekcan.hpotsirhc" class="oemail">ed.xmg@ekcan.hpotsirhc</a></span>.</p><p><span class="fm-affl">Torsten R&#x000fc;lker, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@rekleur.t" class="oemail">ed.sb-ut@rekleur.t</a></span>.</p><p><span class="fm-affl">Thomas Schirrmann, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@nnamrrihcs.ht" class="oemail">ed.sb-ut@nnamrrihcs.ht</a></span>.</p><p><span class="fm-affl">Hans-J&#x000fc;rgen Marschall, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.bwb@llahcsramnegreujsnah" class="oemail">gro.bwb@llahcsramnegreujsnah</a></span>.</p><p><span class="fm-affl">Michael Hust, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@tsuh.m" class="oemail">ed.sb-ut@tsuh.m</a></span>.</p><p><span class="fm-affl">Stefan D&#x000fc;bel, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.sb-ut@lebeud.s" class="oemail">ed.sb-ut@lebeud.s</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Kubes V, Rios FA. The causative agent of infectious equine encephalomytitis in Venezuela. <span><span class="ref-journal">Science. </span>1939;<span class="ref-vol">90</span>(2323):20\xe2\x80\x9321. doi: 10.1126/science.90.2323.20.</span> [<a href="/pubmed/17818578" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.90.2323.20" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+causative+agent+of+infectious+equine+encephalomytitis+in+Venezuela&amp;author=V+Kubes&amp;author=FA+Rios&amp;volume=90&amp;issue=2323&amp;publication_year=1939&amp;pages=20-21&amp;pmid=17818578&amp;doi=10.1126/science.90.2323.20&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC. Evolutionary Relationships and Systematics of the Alphaviruses. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:10118\xe2\x80\x9310131. doi: 10.1128/JVI.75.21.10118-10131.2001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114586/">PMC free article</a>]</span> [<a href="/pubmed/11581380" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.75.21.10118-10131.2001" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Evolutionary+Relationships+and+Systematics+of+the+Alphaviruses&amp;author=AM+Powers&amp;author=AC+Brault&amp;author=Y+Shirako&amp;author=EG+Strauss&amp;author=W+Kang&amp;volume=75&amp;publication_year=2001&amp;pages=10118-10131&amp;pmid=11581380&amp;doi=10.1128/JVI.75.21.10118-10131.2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. <span><span class="ref-journal">Microbiol Rev. </span>1994;<span class="ref-vol">58</span>:491\xe2\x80\x93562.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC372977/">PMC free article</a>]</span> [<a href="/pubmed/7968923" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol+Rev&amp;title=The+alphaviruses:+gene+expression,+replication,+and+evolution&amp;author=JH+Strauss&amp;author=EG+Strauss&amp;volume=58&amp;publication_year=1994&amp;pages=491-562&amp;pmid=7968923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Johnson KM, Martin DH.  Venezuelan equine encephalitis. In: Brandley CA, Cornelius CE, editors. <span class="ref-journal">Advances in the veterinary science and comparitive medicine.</span> New York and London: Academic Press; 1974. pp. 79\xe2\x80\x93116. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Advances+in+the+veterinary+science+and+comparitive+medicine&amp;author=KM+Johnson&amp;author=DH+Martin&amp;publication_year=1974&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Hawley RJ, Eitzen EM. Biological weapons &#x02013; a primer for microbioligist. <span><span class="ref-journal">Annu Rev Microbiol. </span>2001;<span class="ref-vol">55</span>:235\xe2\x80\x93253. doi: 10.1146/annurev.micro.55.1.235.</span> [<a href="/pubmed/11544355" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.micro.55.1.235" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Microbiol&amp;title=Biological+weapons+&#x02013;+a+primer+for+microbioligist&amp;author=RJ+Hawley&amp;author=EM+Eitzen&amp;volume=55&amp;publication_year=2001&amp;pages=235-253&amp;pmid=11544355&amp;doi=10.1146/annurev.micro.55.1.235&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Powers AM, Oberste MS, Brault AC, Rico-Hesse R, Schmura SM, Smith JF, Kang W, Sweeney WP, Weaver SC. Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus. <span><span class="ref-journal">J Virol. </span>1997;<span class="ref-vol">71</span>:6697\xe2\x80\x936705.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC191949/">PMC free article</a>]</span> [<a href="/pubmed/9261393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Repeated+emergence+of+epidemic/epizootic+Venezuelan+equine+encephalitis+from+a+single+genotype+of+enzootic+subtype+ID+virus&amp;author=AM+Powers&amp;author=MS+Oberste&amp;author=AC+Brault&amp;author=R+Rico-Hesse&amp;author=SM+Schmura&amp;volume=71&amp;publication_year=1997&amp;pages=6697-6705&amp;pmid=9261393&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, Tesh RB. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. <span><span class="ref-journal">Lancet. </span>1996;<span class="ref-vol">348</span>:436\xe2\x80\x93440. doi: 10.1016/S0140-6736(96)02275-1.</span> [<a href="/pubmed/8709783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(96)02275-1" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Re-emergence+of+epidemic+Venezuelan+equine+encephalomyelitis+in+South+America.+VEE+Study+Group&amp;author=SC+Weaver&amp;author=R+Salas&amp;author=R+Rico-Hesse&amp;author=GV+Ludwig&amp;author=MS+Oberste&amp;volume=348&amp;publication_year=1996&amp;pages=436-440&amp;pmid=8709783&amp;doi=10.1016/S0140-6736(96)02275-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Sanchez JL, Takafuji ET, Lednar WM, LeDuc JW, Macasaet FF, Mangiafico JA, Rosato RR, Driggers DP, Haecker JC. Venezuelan equine encephalomyelitis: Report of an outbreak associated with jungle exposure. <span><span class="ref-journal">Mil Med. </span>1984;<span class="ref-vol">149</span>:618\xe2\x80\x93621.</span> [<a href="/pubmed/6438552" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mil+Med&amp;title=Venezuelan+equine+encephalomyelitis:+Report+of+an+outbreak+associated+with+jungle+exposure&amp;author=JL+Sanchez&amp;author=ET+Takafuji&amp;author=WM+Lednar&amp;author=JW+LeDuc&amp;author=FF+Macasaet&amp;volume=149&amp;publication_year=1984&amp;pages=618-621&amp;pmid=6438552&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Sudia WD, Newhouse VF, Beadle ID, Miller DL, Johnston JG Jr, Young R, Calisher CH, Maness K. Epidemic Venezuelan equine encephalitis in North America in 1971: vector studies. <span><span class="ref-journal">Am J Epidemiol. </span>1975;<span class="ref-vol">101</span>:17\xe2\x80\x9335.</span> [<a href="/pubmed/235212" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;title=Epidemic+Venezuelan+equine+encephalitis+in+North+America+in+1971:+vector+studies&amp;author=WD+Sudia&amp;author=VF+Newhouse&amp;author=ID+Beadle&amp;author=DL+Miller&amp;author=Jr+Johnston+JG&amp;volume=101&amp;publication_year=1975&amp;pages=17-35&amp;pmid=235212&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Franck P.  <span class="ref-journal">Venezuelan Encephalitis.</span> Washington DC: Pan American Health Organization.; 1972. Round table on epidemic control; pp. 400\xe2\x80\x93401. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Venezuelan+Encephalitis&amp;author=P+Franck&amp;publication_year=1972&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Canceres FM, Aristizabal G, Martinez JW, Revelo D, De la Hoz F, Boshell J, Camacho T, Calderon L, Olano VA, Villareal LI, Roselli D, Alvarez G, Ludwig G, Tsai T. Epidemic Venezuelan equine encephalitis in La Guajira Colombia, 1995. <span><span class="ref-journal">J Infect Dis. </span>1997;<span class="ref-vol">175</span>(4):828\xe2\x80\x93832. doi: 10.1086/513978.</span> [<a href="/pubmed/9086137" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F513978" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Epidemic+Venezuelan+equine+encephalitis+in+La+Guajira+Colombia,+1995&amp;author=F+Rivas&amp;author=LA+Diaz&amp;author=VM+Cardenas&amp;author=E+Daza&amp;author=L+Bruzon&amp;volume=175&amp;issue=4&amp;publication_year=1997&amp;pages=828-832&amp;pmid=9086137&amp;doi=10.1086/513978&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Leitenberg M. Biological Weapons in the Twentieth Century: A Review and Analysis. <span><span class="ref-journal">Crit Rev Microbiol. </span>2001;<span class="ref-vol">27</span>(4):267\xe2\x80\x93320. doi: 10.1080/20014091096774.</span> [<a href="/pubmed/11791799" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F20014091096774" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Microbiol&amp;title=Biological+Weapons+in+the+Twentieth+Century:+A+Review+and+Analysis&amp;author=M+Leitenberg&amp;volume=27&amp;issue=4&amp;publication_year=2001&amp;pages=267-320&amp;pmid=11791799&amp;doi=10.1080/20014091096774&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Hoke CH. History of U.S. Military Contributions to the Study of viral Encephalitis. <span><span class="ref-journal">Military Medicine. </span>2005;<span class="ref-vol">170</span>:92\xe2\x80\x93105. doi: 10.7205/MILMED.170.4S.92.</span> [<a href="/pubmed/15916288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7205%2FMILMED.170.4S.92" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Military+Medicine&amp;title=History+of+U.S.+Military+Contributions+to+the+Study+of+viral+Encephalitis&amp;author=CH+Hoke&amp;volume=170&amp;publication_year=2005&amp;pages=92-105&amp;pmid=15916288&amp;doi=10.7205/MILMED.170.4S.92&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Reed DS, Lind CM, Sullivan LJ, Pratt WD, Parker MD. Aerosol Infection of Cynomolgus Macaques with Enzootic Strains of Venezuelan Equine Encephalitis Viruses. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">189</span>(6):1013\xe2\x80\x931017. doi: 10.1086/382281.</span> [<a href="/pubmed/14999604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F382281" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Aerosol+Infection+of+Cynomolgus+Macaques+with+Enzootic+Strains+of+Venezuelan+Equine+Encephalitis+Viruses&amp;author=DS+Reed&amp;author=CM+Lind&amp;author=LJ+Sullivan&amp;author=WD+Pratt&amp;author=MD+Parker&amp;volume=189&amp;issue=6&amp;publication_year=2004&amp;pages=1013-1017&amp;pmid=14999604&amp;doi=10.1086/382281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Johnstone RE, Peters CJ.  Alphaviruses. In: Fields BN, Knipe DM, Howley PM, editors. <span class="ref-journal">Fields virology.</span> 3. Philadelphia, New York: Lippincott-Raven; 1995. pp. 843\xe2\x80\x93898. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Fields+virology&amp;author=RE+Johnstone&amp;author=CJ+Peters&amp;publication_year=1995&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Smith JF, Davis K, Hart MK, Ludwig GV, McClain DJ, Parker MD, Pratt WD.  <span class="ref-journal">Textbook of Military Medicine; Medical Aspects of Chemical and Biological Warfare.</span> Washington DC: Office of surgeon general; 1997. Viral encephalitides; pp. 561\xe2\x80\x93589. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Textbook+of+Military+Medicine;+Medical+Aspects+of+Chemical+and+Biological+Warfare&amp;author=JF+Smith&amp;author=K+Davis&amp;author=MK+Hart&amp;author=GV+Ludwig&amp;author=DJ+McClain&amp;publication_year=1997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="mixed-citation">Blue Book, Sixth Edition, April 2005. US Army Medical Research Institute of Infectious Disease (USAMRIID), Published by USAMRIID, the lead medical research laboratory for the US Biological Defense Research Program. [<a href="http://www.usamriid.army.mil/education/instruct.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.usamriid.army.mil/education/instruct.htm</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domain. <span><span class="ref-journal">Nature. </span>1990;<span class="ref-vol">348</span>:552\xe2\x80\x93554. doi: 10.1038/348552a0.</span> [<a href="/pubmed/2247164" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F348552a0" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Phage+antibodies:+filamentous+phage+displaying+antibody+variable+domain&amp;author=J+McCafferty&amp;author=AD+Griffiths&amp;author=G+Winter&amp;author=DJ+Chiswell&amp;volume=348&amp;publication_year=1990&amp;pages=552-554&amp;pmid=2247164&amp;doi=10.1038/348552a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Breitling F, D&#x000fc;bel S, Seehaus T, Kleewinghaus I, Little M. A surface expression vector for antibody screening. <span><span class="ref-journal">Gene. </span>1991;<span class="ref-vol">104</span>:1047\xe2\x80\x93153. doi: 10.1016/0378-1119(91)90244-6.</span> [<a href="/pubmed/1916287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0378-1119(91)90244-6" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=A+surface+expression+vector+for+antibody+screening&amp;author=F+Breitling&amp;author=S+D&#x000fc;bel&amp;author=T+Seehaus&amp;author=I+Kleewinghaus&amp;author=M+Little&amp;volume=104&amp;publication_year=1991&amp;pages=1047-153&amp;doi=10.1016/0378-1119(91)90244-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. <span><span class="ref-journal">Nature. </span>1991;<span class="ref-vol">352</span>:624\xe2\x80\x93628. doi: 10.1038/352624a0.</span> [<a href="/pubmed/1907718" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F352624a0" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Making+antibody+fragments+using+phage+display+libraries&amp;author=T+Clackson&amp;author=HR+Hoogenboom&amp;author=AD+Griffiths&amp;author=G+Winter&amp;volume=352&amp;publication_year=1991&amp;pages=624-628&amp;pmid=1907718&amp;doi=10.1038/352624a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. <span><span class="ref-journal">Nucl Acids Res. </span>1991;<span class="ref-vol">19</span>:4133\xe2\x80\x934137. doi: 10.1093/nar/19.15.4133.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC328552/">PMC free article</a>]</span> [<a href="/pubmed/1908075" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2F19.15.4133" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucl+Acids+Res&amp;title=Multi-subunit+proteins+on+the+surface+of+filamentous+phage:+methodologies+for+displaying+antibody+(Fab)+heavy+and+light+chains&amp;author=HR+Hoogenboom&amp;author=AD+Griffiths&amp;author=KS+Johnson&amp;author=DJ+Chiswell&amp;author=P+Hudson&amp;volume=19&amp;publication_year=1991&amp;pages=4133-4137&amp;pmid=1908075&amp;doi=10.1093/nar/19.15.4133&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Better M, Chang CP, Robinson RR, Horwitz AH. Escherichia coli secretion of an active chimeric antibody fragment. <span><span class="ref-journal">Science. </span>1988;<span class="ref-vol">240</span>:1041\xe2\x80\x931043. doi: 10.1126/science.3285471.</span> [<a href="/pubmed/3285471" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.3285471" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Escherichia+coli+secretion+of+an+active+chimeric+antibody+fragment&amp;author=M+Better&amp;author=CP+Chang&amp;author=RR+Robinson&amp;author=AH+Horwitz&amp;volume=240&amp;publication_year=1988&amp;pages=1041-1043&amp;pmid=3285471&amp;doi=10.1126/science.3285471&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Huston JS, Levinson D, Mudgett HM, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoloreri RE, Haber E, Crea R, Oppermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digosin single-chain Fv analogue produced in <em>Escherichia coli</em>. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1988;<span class="ref-vol">85</span>:5879\xe2\x80\x935883. doi: 10.1073/pnas.85.16.5879.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC281868/">PMC free article</a>]</span> [<a href="/pubmed/3045807" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.85.16.5879" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Protein+engineering+of+antibody+binding+sites:+recovery+of+specific+activity+in+an+anti-digosin+single-chain+Fv+analogue+produced+in+Escherichia+coli&amp;author=JS+Huston&amp;author=D+Levinson&amp;author=HM+Mudgett&amp;author=MS+Tai&amp;author=J+Novotny&amp;volume=85&amp;publication_year=1988&amp;pages=5879-5883&amp;pmid=3045807&amp;doi=10.1073/pnas.85.16.5879&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Konthur Z, Hust M, D&#x000fc;bel S. Perspectives for systematic in vitro antibody generation. <span><span class="ref-journal">Gene. </span>2005;<span class="ref-vol">364</span>:19\xe2\x80\x9329. doi: 10.1016/j.gene.2005.05.042.</span> [<a href="/pubmed/16126351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.gene.2005.05.042" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Perspectives+for+systematic+in+vitro+antibody+generation&amp;author=Z+Konthur&amp;author=M+Hust&amp;author=S+D&#x000fc;bel&amp;volume=364&amp;publication_year=2005&amp;pages=19-29&amp;pmid=16126351&amp;doi=10.1016/j.gene.2005.05.042&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Hust M, D&#x000fc;bel S, Schirrmann T. Selection of recombinant antibodies from antibody gene libraries. <span><span class="ref-journal">Methods Mol Biol. </span>2007;<span class="ref-vol">408</span>:243\xe2\x80\x93255. doi: 10.1007/978-1-59745-547-3_14.</span> [<a href="/pubmed/18314587" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2F978-1-59745-547-3_14" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Mol+Biol&amp;title=Selection+of+recombinant+antibodies+from+antibody+gene+libraries&amp;author=M+Hust&amp;author=S+D&#x000fc;bel&amp;author=T+Schirrmann&amp;volume=408&amp;publication_year=2007&amp;pages=243-255&amp;pmid=18314587&amp;doi=10.1007/978-1-59745-547-3_14&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Brink EN Van den, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:1635\xe2\x80\x931644. doi: 10.1128/JVI.79.3.1635-1644.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC544131/">PMC free article</a>]</span> [<a href="/pubmed/15650189" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.79.3.1635-1644.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Molecular+and+biological+characterization+of+human+monoclonal+antibodies+binding+to+the+spike+and+nucleocapsid+proteins+of+severe+acute+respiratory+syndrome+coronavirus&amp;author=EN+Van+den+Brink&amp;author=J+Ter+Meulen&amp;author=F+Cox&amp;author=MA+Jongeneelen&amp;author=A+Thijsse&amp;volume=79&amp;publication_year=2005&amp;pages=1635-1644&amp;pmid=15650189&amp;doi=10.1128/JVI.79.3.1635-1644.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Rodriguez-Diaz J, Monedero V, Perez-Martinez G, Buesa J. Single-chain variable fragment (scFv) antibodies against rotavirus NSP4 enterotoxin generated by phage display. <span><span class="ref-journal">J Virol Methods. </span>2004;<span class="ref-vol">121</span>(2):231\xe2\x80\x93238. doi: 10.1016/j.jviromet.2004.07.002.</span> [<a href="/pubmed/15381361" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jviromet.2004.07.002" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Single-chain+variable+fragment+(scFv)+antibodies+against+rotavirus+NSP4+enterotoxin+generated+by+phage+display&amp;author=J+Rodriguez-Diaz&amp;author=V+Monedero&amp;author=G+Perez-Martinez&amp;author=J+Buesa&amp;volume=121&amp;issue=2&amp;publication_year=2004&amp;pages=231-238&amp;pmid=15381361&amp;doi=10.1016/j.jviromet.2004.07.002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Don&#x000e0; MG, Giorgi C, Accardi L. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis. <span><span class="ref-journal">BMC Cancer. </span>2007;<span class="ref-vol">7</span>:25. doi: 10.1186/1471-2407-7-25.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1797048/">PMC free article</a>]</span> [<a href="/pubmed/17266749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2407-7-25" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=Characterization+of+antibodies+in+single-chain+format+against+the+E7+oncoprotein+of+the+human+papillomavirus+type+16+and+their+improvement+by+mutagenesis&amp;author=MG+Don&#x000e0;&amp;author=C+Giorgi&amp;author=L+Accardi&amp;volume=7&amp;publication_year=2007&amp;pages=25&amp;pmid=17266749&amp;doi=10.1186/1471-2407-7-25&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Velappan N, Martinez JS, Valero R, Chasteen L, Ponce L, Bondu-Hawkins V, Kelly C, Pavlik P, Hjelle B, Bradbury AR. Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein. <span><span class="ref-journal">J Immunol Methods. </span>2007;<span class="ref-vol">321</span>(1-2):60\xe2\x80\x9369. doi: 10.1016/j.jim.2007.01.011.</span> [<a href="/pubmed/17336997" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jim.2007.01.011" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=Selection+and+characterization+of+scFv+antibodies+against+the+Sin+Nombre+hantavirus+nucleocapsid+protein&amp;author=N+Velappan&amp;author=JS+Martinez&amp;author=R+Valero&amp;author=L+Chasteen&amp;author=L+Ponce&amp;volume=321&amp;issue=1-2&amp;publication_year=2007&amp;pages=60-69&amp;pmid=17336997&amp;doi=10.1016/j.jim.2007.01.011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">De Carvalho NC, Williamson RA, Parren PW, Lundkvist A, Burton DR, Bj&#x000f6;hrling E. Neutralizing human Fab fragments against measles virus recovered by phage display. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:251\xe2\x80\x93258. doi: 10.1128/JVI.76.1.251-258.2002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC135717/">PMC free article</a>]</span> [<a href="/pubmed/11739690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.76.1.251-258.2002" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Neutralizing+human+Fab+fragments+against+measles+virus+recovered+by+phage+display&amp;author=NC+De+Carvalho&amp;author=RA+Williamson&amp;author=PW+Parren&amp;author=A+Lundkvist&amp;author=DR+Burton&amp;volume=76&amp;publication_year=2002&amp;pages=251-258&amp;pmid=11739690&amp;doi=10.1128/JVI.76.1.251-258.2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Koch J, Liang M, Queitsch I, Kraus AA, Bautz EKF. Human recombinant neutralizing antibodies against Hantaan virus G2 protein. <span><span class="ref-journal">Virology. </span>2003;<span class="ref-vol">308</span>:64\xe2\x80\x9373. doi: 10.1016/S0042-6822(02)00094-6.</span> [<a href="/pubmed/12706090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0042-6822(02)00094-6" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Human+recombinant+neutralizing+antibodies+against+Hantaan+virus+G2+protein&amp;author=J+Koch&amp;author=M+Liang&amp;author=I+Queitsch&amp;author=AA+Kraus&amp;author=EKF+Bautz&amp;volume=308&amp;publication_year=2003&amp;pages=64-73&amp;pmid=12706090&amp;doi=10.1016/S0042-6822(02)00094-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Duan J, Ji X, Feng J, Han W, Zhang P, Cao W, Guo X, Qi C, Yang D, Jin G, Gao G, Yan X. A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein. <span><span class="ref-journal">Antivir Ther. </span>2006;<span class="ref-vol">11</span>:117\xe2\x80\x93123.</span> [<a href="/pubmed/16518967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antivir+Ther&amp;title=A+human+neutralizing+antibody+against+a+conformational+epitope+shared+by+oligomeric+SARS+S1+protein&amp;author=J+Duan&amp;author=X+Ji&amp;author=J+Feng&amp;author=W+Han&amp;author=P+Zhang&amp;volume=11&amp;publication_year=2006&amp;pages=117-123&amp;pmid=16518967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Calisher CH, Karabatsos N, Lazuick JS, Monath TP, Wolff KL. Reevaluation of the western equine encephalitis antigenic complex of alphaviruses(family Togaviridae) as determined by neutralization tests. <span><span class="ref-journal">Am J Trop Med Hyg. </span>1988;<span class="ref-vol">38</span>:447\xe2\x80\x9352.</span> [<a href="/pubmed/2833129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=Reevaluation+of+the+western+equine+encephalitis+antigenic+complex+of+alphaviruses(family+Togaviridae)+as+determined+by+neutralization+tests&amp;author=CH+Calisher&amp;author=N+Karabatsos&amp;author=JS+Lazuick&amp;author=TP+Monath&amp;author=KL+Wolff&amp;volume=38&amp;publication_year=1988&amp;pages=447-52&amp;pmid=2833129&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Nagata LP, Hu WG, Parker M, Chau D, Rayner GA, Schmaltz FL, Wong JP. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. <span><span class="ref-journal">J Gen Virol. </span>2006;<span class="ref-vol">87</span>:2353\xe2\x80\x932361. doi: 10.1099/vir.0.81815-0.</span> [<a href="/pubmed/16847131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1099%2Fvir.0.81815-0" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Infectivity+variation+and+genetic+diversity+among+strains+of+Western+equine+encephalitis+virus&amp;author=LP+Nagata&amp;author=WG+Hu&amp;author=M+Parker&amp;author=D+Chau&amp;author=GA+Rayner&amp;volume=87&amp;publication_year=2006&amp;pages=2353-2361&amp;pmid=16847131&amp;doi=10.1099/vir.0.81815-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Greiser-Wilke IM, Moennig M, Kaaden OR, Shope R. Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies. <span><span class="ref-journal">J Clin Microbiol. </span>1991;<span class="ref-vol">29</span>:131\xe2\x80\x93137.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC269716/">PMC free article</a>]</span> [<a href="/pubmed/1847149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Detection+of+alphaviruses+in+a+genus-specific+antigen+capture+enzyme+immunoassay+using+monoclonal+antibodies&amp;author=IM+Greiser-Wilke&amp;author=M+Moennig&amp;author=OR+Kaaden&amp;author=R+Shope&amp;volume=29&amp;publication_year=1991&amp;pages=131-137&amp;pmid=1847149&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Mathews JJ, Roehrig JT. Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. <span><span class="ref-journal">J Immunol. </span>1982;<span class="ref-vol">129</span>:2763\xe2\x80\x932767.</span> [<a href="/pubmed/6183343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Determination+of+the+protective+epitopes+on+the+glycoproteins+of+Venezuelan+equine+encephalomyelitis+virus+by+passive+transfer+of+monoclonal+antibodies&amp;author=JJ+Mathews&amp;author=JT+Roehrig&amp;volume=129&amp;publication_year=1982&amp;pages=2763-2767&amp;pmid=6183343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Roehrig JT, Hunt AR, Kinney RM, Mathews JH. In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. <span><span class="ref-journal">Virology. </span>1988;<span class="ref-vol">165</span>:66\xe2\x80\x9373. doi: 10.1016/0042-6822(88)90659-9.</span> [<a href="/pubmed/2455383" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0042-6822(88)90659-9" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=In+vitro+mechanisms+of+monoclonal+antibody+neutralization+of+alphaviruses&amp;author=JT+Roehrig&amp;author=AR+Hunt&amp;author=RM+Kinney&amp;author=JH+Mathews&amp;volume=165&amp;publication_year=1988&amp;pages=66-73&amp;pmid=2455383&amp;doi=10.1016/0042-6822(88)90659-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Hunt AR, Roehrig JT. Localization of a protective epitopeon a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challengeand is immunogenic in horses. <span><span class="ref-journal">Vaccine. </span>1995;<span class="ref-vol">13</span>:281\xe2\x80\x93288. doi: 10.1016/0264-410X(95)93315-Z.</span> [<a href="/pubmed/7543231" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0264-410X(95)93315-Z" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Localization+of+a+protective+epitopeon+a+Venezuelan+equine+encephalomyelitis+(VEE)+virus+peptide+that+protects+mice+from+both+epizootic+and+enzootic+VEE+virus+challengeand+is+immunogenic+in+horses&amp;author=AR+Hunt&amp;author=JT+Roehrig&amp;volume=13&amp;publication_year=1995&amp;pages=281-288&amp;pmid=7543231&amp;doi=10.1016/0264-410X(95)93315-Z&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Hunt AR, Frederickson S, Hinkel C, Bowdish KS, Roehrig JT. A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus. <span><span class="ref-journal">J Gen Virol. </span>2006;<span class="ref-vol">87</span>:2467\xe2\x80\x932476. doi: 10.1099/vir.0.81925-0.</span> [<a href="/pubmed/16894184" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1099%2Fvir.0.81925-0" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=A+humanized+murine+monoclonal+antibody+protects+mice+either+before+or+after+challenge+with+virulent+Venezuelan+equine+encephalomyelitis+virus&amp;author=AR+Hunt&amp;author=S+Frederickson&amp;author=C+Hinkel&amp;author=KS+Bowdish&amp;author=JT+Roehrig&amp;volume=87&amp;publication_year=2006&amp;pages=2467-2476&amp;pmid=16894184&amp;doi=10.1099/vir.0.81925-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Roehrig JT, Mathews JH. The neutralization site on the E2glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. <span><span class="ref-journal">Virology. </span>1985;<span class="ref-vol">142</span>:347\xe2\x80\x93356. doi: 10.1016/0042-6822(85)90343-5.</span> [<a href="/pubmed/2414905" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0042-6822(85)90343-5" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=The+neutralization+site+on+the+E2glycoprotein+of+Venezuelan+equine+encephalomyelitis+(TC-83)+virus+is+composed+of+multiple+conformationally+stable+epitopes&amp;author=JT+Roehrig&amp;author=JH+Mathews&amp;volume=142&amp;publication_year=1985&amp;pages=347-356&amp;pmid=2414905&amp;doi=10.1016/0042-6822(85)90343-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Wang E, Paessler S, Aguilar PV, Smith DR, Coffey LL, Kang W, Pfeffer M, Olson J, Blair PJ, Guevara C, Estrada-Franco J, Weaver SC. A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2005;<span class="ref-vol">72</span>:805\xe2\x80\x93810.</span> [<a href="/pubmed/15964967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=A+novel,+rapid+assay+for+detection+and+differentiation+of+serotype-specific+antibodies+to+Venezuelan+equine+encephalitis+complex+alphaviruses&amp;author=E+Wang&amp;author=S+Paessler&amp;author=PV+Aguilar&amp;author=DR+Smith&amp;author=LL+Coffey&amp;volume=72&amp;publication_year=2005&amp;pages=805-810&amp;pmid=15964967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Duggan JM, Coates DM, Ulaeto DO. Isolation of single-chain antibody fragments against venezualan equine encephalomyelitis virus from two different immune sources. <span><span class="ref-journal">Viral Immunol. </span>2001;<span class="ref-vol">14</span>:263\xe2\x80\x93273. doi: 10.1089/088282401753266774.</span> [<a href="/pubmed/11572636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2F088282401753266774" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Viral+Immunol&amp;title=Isolation+of+single-chain+antibody+fragments+against+venezualan+equine+encephalomyelitis+virus+from+two+different+immune+sources&amp;author=JM+Duggan&amp;author=DM+Coates&amp;author=DO+Ulaeto&amp;volume=14&amp;publication_year=2001&amp;pages=263-273&amp;pmid=11572636&amp;doi=10.1089/088282401753266774&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Guo YC, Zhou YF, Zhang XE, Zhang ZP, Qiao YM, Bi LJ, Wen JK, Liang MF, Zhang JB. Phage display mediated immuno-PCR. <span><span class="ref-journal">Nucleic Acids Res. </span>2006;<span class="ref-vol">34</span>:e62. doi: 10.1093/nar/gkl260.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1458518/">PMC free article</a>]</span> [<a href="/pubmed/16682441" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkl260" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=Phage+display+mediated+immuno-PCR&amp;author=YC+Guo&amp;author=YF+Zhou&amp;author=XE+Zhang&amp;author=ZP+Zhang&amp;author=YM+Qiao&amp;volume=34&amp;publication_year=2006&amp;pages=e62&amp;pmid=16682441&amp;doi=10.1093/nar/gkl260&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Spearman C. The method of right and wrong cases (constat stimuli) without Gauss formulae. <span><span class="ref-journal">Brit J Psychol. </span>1908;<span class="ref-vol">2</span>:227\xe2\x80\x93242.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brit+J+Psychol&amp;title=The+method+of+right+and+wrong+cases+(constat+stimuli)+without+Gauss+formulae&amp;author=C+Spearman&amp;volume=2&amp;publication_year=1908&amp;pages=227-242&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Kaerber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. <span><span class="ref-journal">Arch Exp Pathol Pharmakol. </span>1931;<span class="ref-vol">162</span>:480\xe2\x80\x93483. doi: 10.1007/BF01863914.</span> [<a href="//dx.doi.org/10.1007%2FBF01863914" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Exp+Pathol+Pharmakol&amp;title=Beitrag+zur+kollektiven+Behandlung+pharmakologischer+Reihenversuche&amp;author=G+Kaerber&amp;volume=162&amp;publication_year=1931&amp;pages=480-483&amp;doi=10.1007/BF01863914&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Berge TO, Banks IS, Tiggert WD. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells. <span><span class="ref-journal">American Journal of Hygiene. </span>1961;<span class="ref-vol">73</span>:209\xe2\x80\x93218.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Hygiene&amp;title=Attenuation+of+Venezuelan+equine+encephalomyelitis+virus+by+in+vitro+cultivation+in+guinea-pig+heart+cells&amp;author=TO+Berge&amp;author=IS+Banks&amp;author=WD+Tiggert&amp;volume=73&amp;publication_year=1961&amp;pages=209-218&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Frolov IV, Kolykhalov AA, Volchakov VE, Netesov SV, Sandakhchiev LS. Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus. <span><span class="ref-journal">Dokl Akad Nauk SSSR. </span>1991;<span class="ref-vol">318</span>:1488\xe2\x80\x931491.</span> [<a href="/pubmed/1914828" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dokl+Akad+Nauk+SSSR&amp;title=Comparison+of+the+amino+acid+sequence+of+structural+proteins+from+attenuated+and+pathogenic+strains+of+the+Venezuelan+equine+encephalomyelitis+virus&amp;author=IV+Frolov&amp;author=AA+Kolykhalov&amp;author=VE+Volchakov&amp;author=SV+Netesov&amp;author=LS+Sandakhchiev&amp;volume=318&amp;publication_year=1991&amp;pages=1488-1491&amp;pmid=1914828&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="mixed-citation">Sambrook J, Russell DW, (Eds): Molecular cloning: a laboratory manual. 2001, New York: Cold Spring Harbor Laboratory Press, 3</span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Hust M, Toleikis L, D&#x000fc;bel S.  Antibody phage display. In: D&#x000fc;bel S, editor. <span class="ref-journal">Handbook of therapeutic antibodies.</span> Weinheim: Willey-VCH; 2007. pp. 45\xe2\x80\x9368. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Handbook+of+therapeutic+antibodies&amp;author=M+Hust&amp;author=L+Toleikis&amp;author=S+D&#x000fc;bel&amp;publication_year=2007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, Lefranc MP, D&#x000fc;bel S, Thullier P. A high affinity, human like antibody fragment (scFv) neutralising lethal factor (LF) of Bacillus anthracis by inhibiting the PA-LF complex formation. <span><span class="ref-journal">Antimicro Agents Chem. </span>2007;<span class="ref-vol">51</span>:2758\xe2\x80\x932764. doi: 10.1128/AAC.01528-06.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1932538/">PMC free article</a>]</span> [<a href="/pubmed/17517846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.01528-06" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicro+Agents+Chem&amp;title=A+high+affinity,+human+like+antibody+fragment+(scFv)+neutralising+lethal+factor+(LF)+of+Bacillus+anthracis+by+inhibiting+the+PA-LF+complex+formation&amp;author=T+Pelat&amp;author=M+Hust&amp;author=E+Laffly&amp;author=F+Condemine&amp;author=C+Bottex&amp;volume=51&amp;publication_year=2007&amp;pages=2758-2764&amp;doi=10.1128/AAC.01528-06&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Rondot S, Koch J, Breitling F, D&#x000fc;bel S. A helper phage to improve single-chain antibody presentation in phage display. <span><span class="ref-journal">Nat Biotechnol. </span>2001;<span class="ref-vol">19</span>(1):75\xe2\x80\x9378. doi: 10.1038/83567.</span> [<a href="/pubmed/11135557" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F83567" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=A+helper+phage+to+improve+single-chain+antibody+presentation+in+phage+display&amp;author=S+Rondot&amp;author=J+Koch&amp;author=F+Breitling&amp;author=S+D&#x000fc;bel&amp;volume=19&amp;issue=1&amp;publication_year=2001&amp;pages=75-78&amp;pmid=11135557&amp;doi=10.1038/83567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Hust M, Meysing M, Schirrmann T, Selke M, Meens J, Gerlach GF, D&#x000fc;bel S. Enrichment of open reading frames presented on bacteriophage M13 using Hyperphage. <span><span class="ref-journal">Biotechniques. </span>2006;<span class="ref-vol">41</span>:335\xe2\x80\x93342. doi: 10.2144/000112225.</span> [<a href="/pubmed/16989094" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2144%2F000112225" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biotechniques&amp;title=Enrichment+of+open+reading+frames+presented+on+bacteriophage+M13+using+Hyperphage&amp;author=M+Hust&amp;author=M+Meysing&amp;author=T+Schirrmann&amp;author=M+Selke&amp;author=J+Meens&amp;volume=41&amp;publication_year=2006&amp;pages=335-342&amp;pmid=16989094&amp;doi=10.2144/000112225&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Soltes G, Hust M, Ng KKY, Bansal A, Field J, Stewart DIH, D&#x000fc;bel S, Cha S, Wiersma E. On the influence of vector design on antibody phage display. <span><span class="ref-journal">J Biotechnol. </span>2007;<span class="ref-vol">127</span>(4):626\xe2\x80\x93237. doi: 10.1016/j.jbiotec.2006.08.015.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1866265/">PMC free article</a>]</span> [<a href="/pubmed/16996161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jbiotec.2006.08.015" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biotechnol&amp;title=On+the+influence+of+vector+design+on+antibody+phage+display&amp;author=G+Soltes&amp;author=M+Hust&amp;author=KKY+Ng&amp;author=A+Bansal&amp;author=J+Field&amp;volume=127&amp;issue=4&amp;publication_year=2007&amp;pages=626-237&amp;pmid=16996161&amp;doi=10.1016/j.jbiotec.2006.08.015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Retter I, Althaus HH, M&#x000fc;nch R, M&#x000fc;ller W. VBASE2, an integrative V gene database. <span><span class="ref-journal">Nucleic Acids Res. </span>2005;<span class="ref-vol">33</span>(Database issue):D671\xe2\x80\x93D674. doi: 10.1093/nar/gki088.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC540042/">PMC free article</a>]</span> [<a href="/pubmed/15608286" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgki088" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=VBASE2,+an+integrative+V+gene+database&amp;author=I+Retter&amp;author=HH+Althaus&amp;author=R+M&#x000fc;nch&amp;author=W+M&#x000fc;ller&amp;volume=33&amp;issue=Database+issue&amp;publication_year=2005&amp;pages=D671-D674&amp;pmid=15608286&amp;doi=10.1093/nar/gki088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Mollova S, Retter I, M&#x000fc;ller W. Visualising the immune repertoire. <span><span class="ref-journal">BMC Systems Biology. </span>2007;<span class="ref-vol">1</span>:P30. doi: 10.1186/1752-0509-1-S1-P30.</span> [<a href="//dx.doi.org/10.1186%2F1752-0509-1-S1-P30" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Systems+Biology&amp;title=Visualising+the+immune+repertoire&amp;author=S+Mollova&amp;author=I+Retter&amp;author=W+M&#x000fc;ller&amp;volume=1&amp;publication_year=2007&amp;pages=P30&amp;doi=10.1186/1752-0509-1-S1-P30&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Kirsch M, Zaman M, Meier D, D&#x000fc;bel S, Hust M. Parameters affecting the display of antibodies on phage. <span><span class="ref-journal">J Immunol Methods. </span>2005;<span class="ref-vol">301</span>(1 - 2):173\xe2\x80\x93185. doi: 10.1016/j.jim.2005.04.017.</span> [<a href="/pubmed/15992816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jim.2005.04.017" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=Parameters+affecting+the+display+of+antibodies+on+phage&amp;author=M+Kirsch&amp;author=M+Zaman&amp;author=D+Meier&amp;author=S+D&#x000fc;bel&amp;author=M+Hust&amp;volume=301&amp;issue=1+-+2&amp;publication_year=2005&amp;pages=173-185&amp;pmid=15992816&amp;doi=10.1016/j.jim.2005.04.017&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Li J, Menzel C, Meier D, Zhang C, D&#x000fc;bel S, Jostock T. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. <span><span class="ref-journal">J Immunol Methods. </span>2007;<span class="ref-vol">318</span>(1 - 2):113\xe2\x80\x93124. doi: 10.1016/j.jim.2006.10.010.</span> [<a href="/pubmed/17161420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jim.2006.10.010" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=A+comparative+study+of+different+vector+designs+for+the+mammalian+expression+of+recombinant+IgG+antibodies&amp;author=J+Li&amp;author=C+Menzel&amp;author=D+Meier&amp;author=C+Zhang&amp;author=S+D&#x000fc;bel&amp;volume=318&amp;issue=1+-+2&amp;publication_year=2007&amp;pages=113-124&amp;pmid=17161420&amp;doi=10.1016/j.jim.2006.10.010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2543005&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2543005/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2543005/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2543005/pdf/12896_2007_Article_335.pdf">PDF (2.0M)</a></li> | <li><a href="#" data-citationid="PMC2543005" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2543005%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2543005%2F&amp;text=Development%20of%20human%20antibody%20fragments%20using%20antibody%20phage%20display%20for%20the%20detection%20and%20diagnosis%20of%20Venezuelan%20equine%20encephalitis%20virus%20(VEEV)"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2543005%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18764933" data-aiid="7090815" data-aid="2543005" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2543005" data-md5="f63b695bada1d577ea84fff14feb30b6"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:50:56-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B33C3E99AC4410000000005470547&amp;ncbi_session=8A1B33C3E99B4401_1351SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2543005%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2543005/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B33C3E99B4401_1351SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'